tetrahydrochinazolinderivate than cfr antagonists

摘要

Compounds of the formula (I): and pharmaceutically acceptable salts or prodrugs thereof, wherein m, RSUP1/SUP, RSUP2/SUP, RSUP3/SUP, RSUP4/SUP, RSUP5 /SUPand RSUP6 /SUPare as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for using compounds of formula (I).